Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 8 Issue 2, February 2007

From The Editors

Top of page ⤴

Research Highlight

Top of page ⤴

In Brief

Top of page ⤴

Research Highlight

Top of page ⤴

In Brief

Top of page ⤴

Research Highlight

Top of page ⤴

In the News

Top of page ⤴

Review Article

  • Gene expression is regulated by an intricate interplay of many factors at different levels. To understand how the currently observed expression patterns have evolved, we need to understand the evolution of the individual regulators and the complex regulatory networks that they form.

    • Kevin Chen
    • Nikolaus Rajewsky
    Review Article
  • Variation in life-history strategies is a target for natural selection, and there are many trade-offs between optimal values for different life-history traits. Genomic approaches are starting to contribute to our understanding of the mechanistic basis of these trade-offs.

    • Derek A. Roff
    Review Article
  • Theories of how sex evolved are now being explored experimentally, particularly regarding the roles of epistasis and drift. Although a generalizable theory remains elusive, new models, including theories that involve genetic architecture and robustness, are helping to understand the available evidence.

    • J. Arjan G. M. de Visser
    • Santiago F. Elena
    Review Article
Top of page ⤴

Science and Society

  • To ensure that the benefits of genomics reach all patients, primary health-care providers must be fully aware of current genomic and genetic issues and technologies. This article looks at what needs to be done to achieve this.

    • Alan E. Guttmacher
    • Mary E. Porteous
    • Joseph D. McInerney
    Science and Society
  • Translational research for rare genetic diseases often suffers from a lack of funding. Advocacy groups that support individuals who are affected by such conditions are well placed to motivate and coordinate research that is aimed squarely at generating translational advances.

    • Sharon F. Terry
    • Patrick F. Terry
    • Lionel G. Bercovitch
    Science and Society
Top of page ⤴

Correspondence

Top of page ⤴

Reply

Top of page ⤴

Search

Quick links